FORTIS — Fortis Healthcare Cashflow Statement
0.000.00%
- IN₹509.75bn
- IN₹524.11bn
- IN₹68.93bn
Annual cashflow statement for Fortis Healthcare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 2,394 | 433 | 9,878 | 8,137 | 8,580 |
Depreciation | |||||
Non-Cash Items | 1,263 | 1,168 | -2,016 | -78 | 1,018 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -4,859 | 348 | -2,079 | -2,994 | -2,022 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 1,715 | 4,855 | 8,791 | 8,222 | 11,001 |
Capital Expenditures | -1,559 | -2,185 | -2,155 | -4,472 | -9,425 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 2,163 | 834 | -2,989 | 735 | 561 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 604 | -1,351 | -5,144 | -3,737 | -8,864 |
Financing Cash Flow Items | -2,049 | -1,686 | -1,470 | -1,297 | -1,300 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -8,616 | -1,429 | -5,173 | -4,712 | -865 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -6,266 | 2,120 | -1,525 | -215 | 1,245 |